Portable Gentle Jogger Improves Glycemic Indices in Type 2 Diabetic and Healthy Subjects Living at Home: A Pilot Study

Table 3

Twenty-four-hour average glycemia and indices in diabetic subjects at baseline, during, and after Gentle Jogger jogging device (JD).

	BL	JD2	JD3	JD4	JD5	JD6	JD7	Post JD1	Post JD2
mGlu (mg/dl)	157	130.4	130.6	131.7	127.1	130.8	130.7	140.1	144.2
SD	45.9	35.0	41.1	41.6	33.6	31.3	31.5	42.1	38.6
SUM (mg/dl)	15071	12517	12542	12645	12201	12555	12547	13451	13839
SD	4416	3363	3947	3997	3224	3009	3029	4044	3702
%CV	25.56	18.5	22.45	21.2	20.95	18.03	18.79	22.48	25.78
SD	9.2	5.9	7.9	6.6	9.0	7.0	6.7	7.9	8.7
AUC	3129	2665	2659	2689	2589	2671	2566	275	2829
SD	946.2	734.4	831.8	850.5	661.1	673	602.9	861.9	840.9
% time above range (TAR, glucose 181-250 mg/dl)
Mean	28.0	7.9	9.7	8.3	5.8	3.6	5.9	11.2	19.1
SD	17.4	9.8	13.4	13.7	8.3	5.9	6.5	13.9	16.9
% time in range (TIR, glucose 70-180 mg/dl)
Mean	59.0	77.6	71.0	74.1	77.39	81.5	81.3	70.1	66.7
SD	32.9	30.0	33	32.9	29.7	30.5	30.1	34.4	29.8
% time below range (TBR, )
Mean	3.8	1.8	5.3	3.7	3.9	2.2	0.85	0.8	3.7
SD	5.5	3.3	7.8	9.5	8.6	6.6	1.3	1.1	9.2

Values for twenty-four-hour mean glucose (mGlu, mg/dl), sum of 24 hr glucose (SUM mg/dl), coefficient of variation (%CV) and 24 hr area under the glucose curve (AUC), in type 2 diabetics. % time above range (TAR, glucose 181-250 mg/dl), % time in range (TIR, glucose between 70 and180 mg/dl, and % time below range (TBR, ). Data are expressed as mean (SD, standard deviation). The time points are 24 hr prior to operation of JD (BL), after 2, 3, 4, 5, 6, and 7 days of JD (JD2, JD3, JD4, JD5, JD6, JD7), and 24 and 48 hr after discontinuation of JD (Post JD1, Post JD2). Statistical significance vs. BL, ^† vs. BL.